Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
Molecular Pharmaceutics|February 2, 2012
A novel conjugated agent between dopamine and an A2A adenosine receptor antagonist as a potential anti-Parkinson multitarget approachAlessandro Dalpiaz, Barbara Cacciari, Chiara Beatrice Vicentini, et al.Journal of Medicinal Chemistry|January 7, 2005
Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key studyStefano Moro, Paolo Braiuca, Francesca Deflorian, et al.Current Pharmaceutical Design|October 9, 2002
Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?Pier Giovanni Baraldi, Barbara Cacciari, Pier Andrea Borean, et al.Journal of Medicinal Chemistry|March 3, 2006
Synthesis and biological studies of a new series of 5-heteroarylcarbamoylaminopyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as human A3 adenosine receptor antagonists. Influence of the heteroaryl substituent on binding affinity and molecular modeling investigationsGiorgia Pastorin, Tatiana Da Ros, Chiara Bolcato, et al.Arzneimittel-Forschung|June 4, 2002
Synthesis, biological activity and molecular modeling studies of 1,2,3,4-tetrahydroisoquinoline derivatives as conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor containing a tyrosine moietyPier Giovanni Baraldi, Rimma Makaeva, Maria Giovanna Pavani, et al.Biochemical Pharmacology|March 10, 2012
Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometryEszter Kozma, T Santhosh Kumar, Stephanie Federico, et al.Journal of Medicinal Chemistry|September 19, 2003
Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigationGiorgia Pastorin, Tatiana Da Ros, Giampiero Spalluto, et al.Journal of Medicinal Chemistry|June 19, 2026
Applying Deep-Learning-Driven De Novo Design to Hit Identification: A Case Study on A2A Adenosine Receptor AntagonistsMargherita Persico, Alessandra Micoli, Veronica Salmaso, et al.Journal of Medicinal Chemistry|February 8, 2002
Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonistsPier Giovanni Baraldi, Barbara Cacciari, Stefano Moro, et al.Journal of Medicinal Chemistry|March 24, 2010
The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognitionSiew Lee Cheong, Anna Dolzhenko, Sonja Kachler, et al.Pageof 9